A Phase 2 Randomized Trial of Caloric Restriction and Activity to Reduce Chemoresistance in B-Cell Acute Lymphoblastic Leukemia (IDEAL2)
Details
Age
All Ages
Locations
Childrens Hospital Colorado
Principal Investigator
Lisa Hartman
Study ID
Protocol Number: 22-0837
More information available at ClinicalTrials.gov: NCT05082519
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers